The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer

The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer

Danijel Sikic,1,2 Helge Taubert,1,2 Johannes Breyer,3 Markus Eckstein,2,4 Veronika Weyerer,2,4 Bastian Keck,1,2 Jennifer Kubon,1,2 Wolfgang Otto,3 Thomas S Worst,5 Maximilian C Kriegmair,5 Philipp Erben,5 Arndt Hartmann,2,4 Bernd Wullich,1,2 Ralph M Wirtz,6 Sven Wach1,2 1Department of Urology and Pe...

Full description

Bibliographic Details
Main Authors: Sikic D, Taubert H, Breyer J, Eckstein M, Weyerer V, Keck B, Kubon J, Otto W, Worst TS, Kriegmair MC, Erben P, Hartmann A, Wullich B, Wirtz RM, Wach S
Format: Article
Language:English
Published: Dove Medical Press 2021-08-01
Series:Cancer Management and Research
Subjects:
biomarker
cdkn2a
fgfr3
nmibc
prognosis
Online Access:https://www.dovepress.com/the-prognostic-value-of-fgfr3-expression-in-patients-with-t1-non-muscl-peer-reviewed-fulltext-article-CMAR

Internet

https://www.dovepress.com/the-prognostic-value-of-fgfr3-expression-in-patients-with-t1-non-muscl-peer-reviewed-fulltext-article-CMAR

Similar Items